Assessment of p-value quality in Phase 3 Clinical Trial

来源 :上海交通大学 | 被引量 : 0次 | 上传用户:ty782406826
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  A p-value is a most widely used statistical measure of evidence against a null hypothesis in statistical hypothesis testing and is generally required in Phase 3 clinical trials for drug registration approval process.
其他文献
Principal component analysis(PCA)has been a prominent tool for high-dimensional data analysis.Online algorithms that estimate the principal component by processing streaming data are of tremendous pra
Variance estimation presents challenges in the context of complex survey designs.Conventional variance estimators rely on second-order inclusion probabilities that can be difficult to compute for some
In logistic regression,separation occurs when a linear combination of the predictors can perfectly classify part or all of the observations in the sample,and as a result,finite maximum likelihood esti
This talk introduces an empirical likelihood approach to testing for stochastic ordering between two univariate distributions under right censorship.
The most popular method to model the relationship between the scalar response and the functional predictor is the functional linear model because of its simplicity and easy interpretation.
会议
Assume a common change may occur in a portion of N independent panels and each panel consists of a sequence of independent random variables following a standard exponential family distribution.
Gene set enrichment analyses(GSEA)are powerful inferential methods widely used in genomic research to identify significant gene sets,such as Gene Ontology terms and molecular pathways.
For sequences of random backward nested subspaces as occur,say,in dimension reduction for manifold or stratified space valued data,asymptotic results are derived.
In ultrahigh dimensional data analysis,variable screening has been routinely per-formed before tting complex models with the goal to e ciently reduce data dimension while still keeping majority of th
会议
We discuss the design and testing strategy for a clinical trial involving Combination therapy(A+B),Monotherapy(A),and Placebo(P).